Aclaris Therapeutics, Inc

(NASDAQ:ACRS)

Latest On Aclaris Therapeutics, Inc (ACRS):

Date/Time Type Description Signal Details
2023-05-08 20:31 ESTNewsAclaris Therapeutics, Inc. (ACRS) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 07:15 ESTNewsAclaris Therapeutics GAAP EPS of -$0.42 beats by $0.02, revenue of $2.53M beats by $0.78MN/A
2023-05-05 23:32 ESTNewsAclaris Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-09 12:31 ESTNewsAclaris Therapeutics: Potential Speculative Play After Zunsemetinib Misses Mark On Hidradenitis SuppurativaN/A
2023-03-06 10:16 ESTNewsAclaris stock falls ~35% as zunsemetinib fails mid-stage study in skin disorderN/A
2023-02-23 11:16 ESTNewsAclaris Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $7.75M beats by $5.76MN/A
2023-01-12 19:02 ESTNewsAclaris Therapeutics (ACRS) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2023-01-10 19:15 ESTNewsAclaris Therapeutics Has Strong Upside Potential, But Shares Could Be LowerN/A
2022-12-02 00:46 ESTNewsGoldman Sachs initiates Aclaris at Buy citing potential in lead assetN/A
2022-11-23 08:47 ESTNewsAclaris Therapeutics names CEO as board chair, COO to take helmN/A
2022-10-06 22:31 ESTNewsAclaris initiated as a buy at BTIG on potential of zunsemetinib for autoimmune conditionsN/A
2022-08-26 00:31 ESTNewsAclaris, Lilly ink patent license deal for Olumiant to treat alopecia areataN/A
2022-08-03 16:47 ESTNewsAclaris Therapeutics GAAP EPS of -$0.31 beats by $0.05, revenue of $1.53M misses by $0.08MN/A
2022-08-01 21:32 ESTNewsAclaris Therapeutics gets a new COON/A
2022-06-27 23:02 ESTNewsAclaris Therapeutics appoints Gail Cawkwell as Chief Medical OfficerN/A
2022-05-10 22:48 ESTNewsAclaris Therapeutics GAAP EPS of -$0.31 beats by $0.09, revenue of $1.45M misses by $0.22MN/A
2022-02-24 08:00 ESTNewsAclaris Therapeutics GAAP EPS of -$0.37 misses by $0.01, revenue of $1.5M misses by $0.3MN/A
2022-02-23 12:00 ESTNewsAclaris Therapeutics Q4 2021 Earnings PreviewN/A
2022-02-01 22:01 ESTNewsAclaris Therapeutics appoints chief business officerN/A
2022-01-12 00:16 ESTNewsAclaris falls on the exit of medical chiefN/A
2021-11-02 11:16 ESTNewsAclaris Therapeutics EPS misses by $0.07, misses on revenueN/A
2021-10-02 05:32 ESTNewsAclaris Therapeutics (ACRS) Investor Presentation - SlideshowN/A
2021-09-17 12:18 ESTNewsAclaris Therapeutics (ACRS) Presents At 23rd Annual Global Investment Virtual Conference - SlideshowN/A
2021-08-27 23:16 ESTNewsAclaris announces proposed settlement of shareholder derivative actionN/A
2021-08-05 21:07 ESTNewsAclaris Therapeutics EPS misses by $0.06, beats on revenueN/A
2021-07-24 07:16 ESTNewsAclaris price target raised at Jefferies citing ‘significant stock moving event’N/A
2021-07-20 17:52 ESTNewsAclaris Therapeutics posts promising data from mid-stage atopic dermatitis trialN/A
2021-07-20 17:51 ESTNewsAclaris Therapeutics to raise $75M in stock offeringN/A
2021-07-20 17:51 ESTNewsAclaris to offer $75M in public offering of stock; shares down 16%N/A
2021-07-20 17:49 ESTNewsAclaris to meet competition from Incyte in atopic dermatitisN/A
2021-07-20 17:49 ESTNewsAclaris Therapeutics secures $125M capital via equity raiseN/A
2021-05-07 23:03 ESTNewsAclaris Therapeutics EPS misses by $0.29, beats on revenueN/A
2021-03-16 16:01 ESTNewsAclaris Therapeutics (ACRS) Presents At H.C. Wainwright Global Life Sciences Virtual Conference - SlideshowN/A
2021-03-15 16:01 ESTNewsAclaris completes enrollment of mid-stage trial for atopic dermatitisN/A
2021-03-05 15:01 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $26.67.Buy
2021-03-03 02:01 ESTNewsAclaris Therapeutics: A Potential Big Pharma Deal May Be In The HorizonN/A
2021-02-26 15:01 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$1.04 is estimated for the 2022 year.Sell
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-25 18:35 ESTNewsAclaris Therapeutics EPS misses by $0.04, beats on revenueN/A
2021-02-22 16:16 ESTNewsAclaris Therapeutics stock spikes after speculation of potential sale (update)N/A
2021-02-02 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $20 to $25.Buy
2021-01-21 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $14 to $20.Buy
2021-01-20 13:32 ESTNewsAclaris shares rise 10% after pricing equity offeringN/A
2021-01-20 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.83 to $14.Neutral
2021-01-19 23:31 ESTNewsAclaris Therapeutics readies proposed public offeringN/A
2021-01-19 08:31 ESTNewsAclaris stock surges on positive data from mid-stage rheumatoid arthritis ATI-450 trialN/A
2021-01-16 11:00 ESTNewsStocks To Watch: Earnings Day For Netflix, Intel And Procter & GambleN/A
2020-12-22 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.5 to $5.83.Neutral
2020-12-17 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $4.83 to $5.5.Buy

About Aclaris Therapeutics, Inc (ACRS):

Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational oral, novel, small molecule selective MK2 inhibitor compound that is in phase 2 clinical trial for the treatment of moderate to severe rheumatoid arthritis, COVID-19, and additional immuno-inflammatory diseases; ATI-1777, an investigational topical soft JAK 1/3 inhibitor compound, which is in phase 2a clinical trial to treat moderate to severe atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3 inhibitor compound for the treatment for psoriasis and/or inflammatory bowel disease, as well as A-101 45% topical solution to treat common warts. It also provides contract research services. Aclaris Therapeutics, Inc. has a license and collaboration agreement with Rigel Pharmaceuticals, Inc. for the development and commercialization of JAK inhibitors. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

See Advanced Chart

General

  • Name Aclaris Therapeutics, Inc
  • Symbol ACRS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 57
  • Fiscal Year EndDecember
  • IPO Date2015-10-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aclaristx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 156.98
  • Price/Book (Most Recent Quarter) 32.91
  • Enterprise Value Revenue 184.55
  • Enterprise Value EBITDA 0.05
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$1.38
  • Operating Margin -749%
  • Return on Assets -36%
  • Return on Equity -95%
  • Revenue 6.48 million
  • Earnings Per Share -$4.17
  • Revenue Per Share $0.15
  • Gross Profit -27989000
  • Quarterly Earnings Growth 44.3%
View More

Highlights

  • Market Capitalization 1.29 billion
  • EBITDA -134348000
  • PE Ratio -1.43
  • PEG Ratio -0.13
  • Analyst Target Price $26.67
  • Book Value Per Share $0.84
View More

Share Statistics

  • Shares Outstanding 51.8 million
  • Shares Float 35.44 million
  • % Held by Insiders 964%
  • % Held by Institutions 66.13%
  • Shares Short 758989
  • Shares Short Prior Month 1.45 million
  • Short Ratio 0.72
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.66
  • 52 Week High $26.5
  • 52 Week Low $0.85
  • 50 Day Moving Average 22.3
  • 200 Day Moving Average 9.26
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aclaris Therapeutics, Inc (ACRS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aclaris Therapeutics, Inc (ACRS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$1.58 million-$0.30-$0.26-15.38%
2020-09-302020-11-04$1.45 million-$0.25-$0.3118.03%
2020-06-302020-08-07$N/A-$0.28-$0.3621.13%
2020-03-312020-05-07$1.41 million-$0.37-$0.381.33%
2019-12-312020-02-25$1.1 million-$0.45-$0.39-16.37%
2019-09-302019-11-07$983000-$1.34-$0.69-94.2%
2019-06-302019-08-08$5.87 million-$1.21-$0.75-62.2%
2019-03-312019-05-08$5.04 million-$0.91-$0.80-13.4%
2018-12-312019-03-18$3.67 million-$0.99-$0.98-0.68%
2018-09-302018-11-06$1.63 million-$1.06-$1.3320.1%
2018-06-302018-08-03$3.68 million-$1.01-$1.097.62%
2018-03-312018-05-08$1.12 million-$0.98-$1.002.32%
2017-12-312018-03-12$999000-$0.74-$0.8815.91%
2017-09-302017-11-07$684000-$0.63-$0.8727.59%
2017-06-302017-08-08$N/A-$0.56-$0.7323.29%
2017-03-312017-05-09$N/A-$0.48-$0.5918.64%
2016-12-312017-03-15$N/A-$0.49-$0.6422.83%
2016-09-302016-11-03$N/A-$0.50-$0.6725.65%
2016-06-302016-08-11$N/A-$0.62-$0.654.13%
2016-03-312016-05-11$N/A-$0.65-$0.50-30%
2015-12-312016-03-23$N/A-$0.28-$0.4537.78%
2015-09-302015-10-13$N/A-$5.11-$2.84-79.93%

Aclaris Therapeutics, Inc (ACRS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aclaris Therapeutics, Inc (ACRS) Chart:

Aclaris Therapeutics, Inc (ACRS) News:

Below you will find a list of latest news for Aclaris Therapeutics, Inc (ACRS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aclaris Therapeutics, Inc (ACRS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-1710.7CALL0 5180.13TRUE00
2025-04-1720.05CALL2 45115.28FALSE0.050
2025-04-1730.07CALL0 5288.94FALSE00
2025-04-1740CALL0 0398.83FALSE00
2025-04-1750CALL0 0597.21FALSE00
2025-04-1710.05PUT0 240581.96FALSE00
2025-04-1720PUT0 0151.56TRUE00
2025-04-1730PUT0 0486.58TRUE00
2025-04-1740PUT0 0303.16TRUE00
2025-04-1750PUT0 0377.62TRUE00
2025-05-1610.69CALL0 158134.9TRUE00
2025-05-1620.17CALL45 74129.95FALSE0.170
2025-05-1630.11CALL0 226194.14FALSE00
2025-05-1640.08CALL0 303174.06FALSE00
2025-05-1650.15CALL0 68201.54FALSE00
2025-05-1660.17CALL0 38400.32FALSE00
2025-05-1670.14CALL0 3420.59FALSE00
2025-05-1680.64CALL0 15437.55FALSE00
2025-05-1690.42CALL0 12452.09FALSE00
2025-05-16100.15CALL0 17464.8FALSE00
2025-05-1610PUT0 0130.9FALSE00
2025-05-1620.55PUT0 21120.82TRUE00
2025-05-1631.4PUT0 13154.03TRUE00
2025-05-1642.14PUT0 46266.19TRUE00
2025-05-1650PUT0 0244TRUE00
2025-05-1662.55PUT0 25230.73TRUE00
2025-05-1670PUT0 0289TRUE00
2025-05-1680PUT0 0306.34TRUE00
2025-05-1690PUT0 0321.45TRUE00
2025-05-16100PUT0 0334.83TRUE00
2025-08-1510.6CALL0 13132.6TRUE00
2025-08-1520.25CALL0 3282.83FALSE00
2025-08-1530.3CALL0 2197.49FALSE00
2025-08-1540.35CALL0 10138.63FALSE00
2025-08-1550CALL0 0186.35FALSE00
2025-08-1560CALL0 0186.35FALSE00
2025-08-1510PUT0 0102.61FALSE00
2025-08-1520PUT0 0100.21TRUE00
2025-08-1530PUT0 0148TRUE00
2025-08-1540PUT0 0190.54TRUE00
2025-08-1550PUT0 0184.46TRUE00
2025-08-1560PUT0 0169.01TRUE00
2025-11-2110CALL0 091.24TRUE00
2025-11-2120.45CALL0 296.68FALSE00
2025-11-2130CALL0 0126.89FALSE00
2025-11-2140CALL0 092.73FALSE00
2025-11-2150CALL0 0112.98FALSE00
2025-11-2110PUT0 088.27FALSE00
2025-11-2120PUT0 088.95TRUE00
2025-11-2131.59PUT0 684.53TRUE00
2025-11-2140PUT0 0150.79TRUE00
2025-11-2150PUT0 0168.24TRUE00
2025-12-1911.05CALL0 1585.66TRUE00
2025-12-1920.7CALL0 6124.52FALSE00
2025-12-1930.3CALL0 28124.4FALSE00
2025-12-1940.2CALL1 155110.3FALSE0.20
2025-12-1950.1CALL0 199112.69FALSE00
2025-12-1970.45CALL0 11168.07FALSE00
2025-12-19100.15CALL0 40166.37FALSE00
2025-12-1910PUT0 0122.03FALSE00
2025-12-1920.65PUT0 1113.06TRUE00
2025-12-1930.9PUT0 3111.73TRUE00
2025-12-1942.21PUT0 1108.33TRUE00
2025-12-1950PUT0 0118.35TRUE00
2025-12-1970PUT0 0141.88TRUE00
2025-12-19100PUT0 0151.36TRUE00

Latest ACRS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST80$12.925
Jun 13, 2022 7:59 PM EST22$12.935
Jun 13, 2022 7:59 PM EST19$12.93
Jun 13, 2022 7:59 PM EST24$12.93
Jun 13, 2022 7:59 PM EST5$12.93

Aclaris Therapeutics, Inc (ACRS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2020-03-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1557746/000000000020002443/0000000000-20-002443-index.htm
2019-01-25SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877719000005/0000038777-19-000005-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877720000013/0000038777-20-000013-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000021545719003192/0000215457-19-003192-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506619000849/0000315066-19-000849-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506620000819/0000315066-20-000819-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720004757/0000834237-20-004757-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720009989/0000834237-20-009989-index.htm
2019-08-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542119000589/0000895421-19-000589-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000139/0000895421-20-000139-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000278/0000895421-20-000278-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2019-10-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445419000691/0000904454-19-000691-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000171/0000904454-20-000171-index.htm
2020-07-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000503/0000904454-20-000503-index.htm
2019-07-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514819000691/0000905148-19-000691-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514820000306/0000905148-20-000306-index.htm
2019-01-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957419000663/0000919574-19-000663-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957420001125/0000919574-20-001125-index.htm
2019-10-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002554/0000921895-19-002554-index.htm
2019-11-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002853/0000921895-19-002853-index.htm
2019-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519003037/0000921895-19-003037-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000093583620000140/0000935836-20-000140-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000103738920000090/0001037389-20-000090-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465919049176/0001104659-19-049176-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920021847/0001104659-20-021847-index.htm
2020-03-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920030172/0001104659-20-030172-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920033094/0001104659-20-033094-index.htm
2020-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1557746/000110465920033140/0001104659-20-033140-index.htm
2020-04-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1557746/000110465920050082/0001104659-20-050082-index.htm
2020-04-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920053341/0001104659-20-053341-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920094778/0001104659-20-094778-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920094781/0001104659-20-094781-index.htm
2020-10-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920118249/0001104659-20-118249-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000114420419008093/0001144204-19-008093-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266119001597/0001172661-19-001597-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120000734/0001172661-20-000734-index.htm
2020-10-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120002035/0001172661-20-002035-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001435/0001193805-18-001435-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001441/0001193805-18-001441-index.htm
2019-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000014/0001193805-19-000014-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000067/0001193805-19-000067-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000181/0001193805-19-000181-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-07-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000689/0001193805-19-000689-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380520000193/0001193805-20-000193-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015882/0001209191-19-015882-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015888/0001209191-19-015888-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015892/0001209191-19-015892-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015894/0001209191-19-015894-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015898/0001209191-19-015898-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035829/0001209191-19-035829-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035830/0001209191-19-035830-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035832/0001209191-19-035832-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035835/0001209191-19-035835-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035840/0001209191-19-035840-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035916/0001209191-19-035916-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041174/0001209191-19-041174-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041175/0001209191-19-041175-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119054623/0001209191-19-054623-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002761/0001209191-20-002761-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002767/0001209191-20-002767-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035025/0001209191-20-035025-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035056/0001209191-20-035056-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2020-04-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000123191920000022/0001231919-20-000022-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837018009771/0001558370-18-009771-index.htm
2019-01-188-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000179/0001558370-19-000179-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000521/0001558370-19-000521-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002208/0001558370-19-002208-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837019002211/0001558370-19-002211-index.htm
2019-03-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002649/0001558370-19-002649-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002790/0001558370-19-002790-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003262/0001558370-19-003262-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003265/0001558370-19-003265-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019004465/0001558370-19-004465-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019004494/0001558370-19-004494-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005495/0001558370-19-005495-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005542/0001558370-19-005542-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005736/0001558370-19-005736-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006015/0001558370-19-006015-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006557/0001558370-19-006557-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019007711/0001558370-19-007711-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019007745/0001558370-19-007745-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008497/0001558370-19-008497-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008709/0001558370-19-008709-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008878/0001558370-19-008878-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008933/0001558370-19-008933-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019010383/0001558370-19-010383-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019010425/0001558370-19-010425-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011167/0001558370-19-011167-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011272/0001558370-19-011272-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000075/0001558370-20-000075-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000132/0001558370-20-000132-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020001319/0001558370-20-001319-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837020001325/0001558370-20-001325-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020003444/0001558370-20-003444-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004176/0001558370-20-004176-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004178/0001558370-20-004178-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005715/0001558370-20-005715-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020005744/0001558370-20-005744-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005771/0001558370-20-005771-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006658/0001558370-20-006658-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006989/0001558370-20-006989-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007276/0001558370-20-007276-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007565/0001558370-20-007565-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007743/0001558370-20-007743-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020009808/0001558370-20-009808-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020009814/0001558370-20-009814-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020010689/0001558370-20-010689-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020011154/0001558370-20-011154-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020012486/0001558370-20-012486-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020012488/0001558370-20-012488-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000161577419002509/0001615774-19-002509-index.htm
2020-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1557746/999999999520000907/9999999995-20-000907-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999718009613/9999999997-18-009613-index.htm
2019-05-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999719004164/9999999997-19-004164-index.htm

Aclaris Therapeutics, Inc (ACRS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aclaris Therapeutics, Inc (ACRS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 964%
Institutional Ownership: 6613%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Neal WalkerPresident and CEOBuy96,150.001,025,053.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-03-02Kamil Ali-JacksonChief Legal OfficerBuy17,175.00103,978.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-02Neal WalkerPresident and CEOBuy52,564.001,049,994.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-01David N. GordonChief Medical OfficerBuy87,500.00106,940.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2019-06-26James E Flynn10% Share HolderSell352.004.501,584.531,072,775.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell10,634.004.5147,947.641,073,127.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell13,063.004.5259,077.421,083,761.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell70,135.004.62323,701.081,096,824.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2020-06-01Neal WalkerPresident and CEOBuy73,014.001,107,907.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2019-05-10James E Flynn10% Share HolderSell71,869.006.05434,749.951,166,959.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-09-01Neal WalkerPresident and CEOBuy83,092.001,170,023.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2019-02-01Brett FairChief Commercial OfficerBuy3,875.0011,890.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-05-09James E Flynn10% Share HolderSell172,800.006.161,064,016.001,238,828.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-06-01Kamil Ali-JacksonChief Legal OfficerBuy33,188.00132,387.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2018-12-15Christopher PowalaChief Reg & Develop OfficerBuy1,300.00138,621.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-18Christopher PowalaChief Reg & Develop OfficerBuy1,625.00139,889.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2019-02-01Christopher PowalaChief Reg & Develop OfficerBuy3,400.00142,843.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2018-12-15Frank RuffoChief Financial OfficerBuy1,300.00161,885.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2020-06-06Anand MehraDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-06ANDREW N SCHIFFDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-06Bryan M. ReasonsDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-06-06William D. HumphriesDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2018-12-18Frank RuffoChief Financial OfficerBuy1,250.00162,765.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2020-03-02Christopher P. MolineauxDirectorBuy8,876.0016,558.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2019-12-16Frank RuffoChief Financial OfficerBuy1,300.00166,276.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-02-01Frank RuffoChief Financial OfficerBuy3,875.00166,284.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2020-06-06Andrew Kenneth William PowellDirectorBuy7,333.0016,709.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2019-12-18Frank RuffoChief Financial OfficerBuy1,250.00167,156.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2020-02-03Frank RuffoChief Financial OfficerBuy3,875.00170,675.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-03-02Frank RuffoChief Financial OfficerBuy25,750.00195,117.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-06-01Frank RuffoChief Financial OfficerBuy33,188.00221,143.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-06Christopher P. MolineauxDirectorBuy7,333.0023,891.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-03-02David N. GordonChief Medical OfficerBuy20,600.0024,952.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2018-12-15Stuart ShanlerChief Scientific OfficerBuy1,300.00268,812.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-18Stuart ShanlerChief Scientific OfficerBuy1,450.00269,892.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2019-02-01Stuart ShanlerChief Scientific OfficerBuy3,875.00273,355.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-06-27James E Flynn10% Share HolderSell590,801.002.691,589,668.253,159,165.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-06-26James E Flynn10% Share HolderSell1,352.004.506,086.033,749,966.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell40,850.004.51184,188.573,751,318.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell50,177.004.52226,925.483,792,168.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell269,402.004.621,243,397.993,842,345.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-05-10James E Flynn10% Share HolderSell108,696.006.05657,523.844,111,747.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-05-09James E Flynn10% Share HolderSell261,345.006.161,609,231.844,220,443.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-03-02MAXINE GOWENDirectorBuy4,438.004,438.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2019-07-02David N. GordonChief Medical OfficerBuy6,000.006,000.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2018-12-15Kamil Ali-JacksonChief Legal OfficerBuy1,733.0079,369.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0079,951.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2019-02-01Kamil Ali-JacksonChief Legal OfficerBuy3,875.0083,520.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-12-16Kamil Ali-JacksonChief Legal OfficerBuy1,733.0083,945.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0084,523.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2018-12-18Brett FairChief Commercial OfficerBuy1,750.008,513.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2020-02-03Kamil Ali-JacksonChief Legal OfficerBuy3,875.0088,121.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-03-02Anand MehraDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-02ANDREW N SCHIFFDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-02Bryan M. ReasonsDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-02William D. HumphriesDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-07-02David N. GordonChief Medical OfficerBuy6,000.0088,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2018-12-15Neal WalkerPresident and CEOBuy3,033.00908,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-18Neal WalkerPresident and CEOBuy2,925.00910,957.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2019-12-16Neal WalkerPresident and CEOBuy3,033.00920,378.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-02-01Neal WalkerPresident and CEOBuy10,800.00920,924.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-12-18Neal WalkerPresident and CEOBuy2,925.00922,521.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-02-03Neal WalkerPresident and CEOBuy10,800.00932,578.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-02Andrew Kenneth William PowellDirectorBuy8,876.009,376.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2019-06-27James E Flynn10% Share HolderSell108,674.002.69292,409.13964,101.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm